91 related articles for article (PubMed ID: 291484)
21. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
[No Abstract] [Full Text] [Related]
22. Phase II trials with cis-dichlorodiammineplatinum(II) in the treatment of urothelial cancer.
Yagoda A
Cancer Treat Rep; 1979; 63(9-10):1565-72. PubMed ID: 387226
[TBL] [Abstract][Full Text] [Related]
23. Spontaneous necrosis in osteosarcoma.
Springfield DS; Schakel ME; Spanier SS
Clin Orthop Relat Res; 1991 Feb; (263):233-7. PubMed ID: 1993380
[TBL] [Abstract][Full Text] [Related]
24. Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas.
Karakousis CP; Holtermann OA; Holyoke ED
Cancer Treat Rep; 1979; 63(11-12):2071-5. PubMed ID: 393389
[TBL] [Abstract][Full Text] [Related]
25. [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].
Hayat M; Bayssas M; Brulé G; Cappelaere P; Cattan A; Chauvergne J; Clavel B; Gouveia J; Guerrin J; Pommatau E; Muggia F; Mathé G
Nouv Presse Med; 1979 Mar; 8(15):1231-4. PubMed ID: 375187
[TBL] [Abstract][Full Text] [Related]
26. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
27. [Chemotherapy using cisplatin in bone and soft tissue sarcoma].
Isu K; Goto M; Yamawaki S; Ubayama Y
Gan To Kagaku Ryoho; 1987 Jan; 14(1):100-4. PubMed ID: 3467652
[TBL] [Abstract][Full Text] [Related]
28. Phase II study of high-dose methotrexate in patients with unresectable metastatic osteosarcoma.
Edmonson JH; Creagan ET; Gilchrist GS
Cancer Treat Rep; 1981; 65(5-6):538-9. PubMed ID: 6972255
[No Abstract] [Full Text] [Related]
29. Phase II clinical trial of cis-dichlorodiammineplatinum in gastric cancer.
Lacave AJ; Izarzugaza I; Antón Aparicio LM; Valle Pereda M; Gracia Marco JM; Buesa JM
Am J Clin Oncol; 1983 Feb; 6(1):35-8. PubMed ID: 6682284
[TBL] [Abstract][Full Text] [Related]
30. In vitro thermochemotherapy of human osteosarcoma cells with cis-dichlorodiammineplatinum (II).
Yamane T; Nakabayashi H; Ito S; Sumii H; Kawai A
Hiroshima J Med Sci; 1986 Sep; 35(3):191-5. PubMed ID: 3468096
[No Abstract] [Full Text] [Related]
31. Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.
Merrin CE
Cancer Treat Rep; 1979; 63(9-10):1579-84. PubMed ID: 574057
[No Abstract] [Full Text] [Related]
32. Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II).
Mills RC; Maurer LH; Forcier RJ; Grace WR; Burke GP; Karp DD; Smith RC; Mcintyre OR; Bean C
Cancer Treat Rep; 1977; 61(3):477-9. PubMed ID: 872146
[No Abstract] [Full Text] [Related]
33. A phase II study of cisplatin, ifosfamide and epirubicin combination chemotherapy in adults with nonmetastatic and extremity osteosarcomas.
Basaran M; Bavbek ES; Saglam S; Eralp L; Sakar B; Atalar AC; Bilgic B; Ozger H; Onat H
Oncology; 2007; 72(3-4):255-60. PubMed ID: 18185020
[TBL] [Abstract][Full Text] [Related]
34. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.
Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH
Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225
[TBL] [Abstract][Full Text] [Related]
35. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials.
Eselgrim M; Grunert H; Kühne T; Zoubek A; Kevric M; Bürger H; Jürgens H; Mayer-Steinacker R; Gosheger G; Bielack SS
Pediatr Blood Cancer; 2006 Jul; 47(1):42-50. PubMed ID: 16206218
[TBL] [Abstract][Full Text] [Related]
36. Auditory function in pediatric osteosarcoma patients treated with multiple doses of cis-diamminedichloroplatinum(II).
Ruiz L; Gilden J; Jaffe N; Robertson R; Wang YM
Cancer Res; 1989 Feb; 49(3):742-4. PubMed ID: 2910492
[TBL] [Abstract][Full Text] [Related]
37. Weekly administration of cis-dichlorodiammineplatinum(II) in childhood solid tumors: a Southwest Oncology Group study.
Nitschke R; Fagundo R; Berry DH; Falletta JM
Cancer Treat Rep; 1979 Mar; 63(3):497-9. PubMed ID: 427829
[No Abstract] [Full Text] [Related]
38. Advanced bladder cancer: therapy with cis-dichlorodiammineplatinum(II), adriamycin, and 5-fluorouracil.
Williams SD; Donohue JP; Einhorn LH
Cancer Treat Rep; 1979; 63(9-10):1573-6. PubMed ID: 498156
[TBL] [Abstract][Full Text] [Related]
39. Upfront window trial of topotecan in previously untreated children and adolescents with poor prognosis metastatic osteosarcoma: children's Cancer Group (CCG) 7943.
Seibel NL; Krailo M; Chen Z; Healey J; Breitfeld PP; Drachtman R; Greffe B; Nachman J; Nadel H; Sato JK; Meyers PA; Reaman GH
Cancer; 2007 Apr; 109(8):1646-53. PubMed ID: 17334983
[TBL] [Abstract][Full Text] [Related]
40. Toxic effects of cis-dichlorodiammineplatinum(II) in man.
Von Hoff DD; Schilsky R; Reichert CM; Reddick RL; Rozencweig M; Young RC; Muggia FM
Cancer Treat Rep; 1979; 63(9-10):1527-31. PubMed ID: 387223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
